Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Sep. 22, 2021

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sep. 22, 2021

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Remix Therapeutics patents RNA splicing modulators

Sep. 21, 2021

New PBP3 ligands identified at Bicycletx

Sep. 21, 2021

UCB describes new IL-17 modulators

Sep. 21, 2021

Kissei Pharmaceutical discovers EGLN1 inhibitors

Sep. 20, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

New GCN2 inhibitors identified at Black Belt TX

Sep. 20, 2021

Gilead describes new antiviral nucleoside analogues

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...